HSH40 infusion significantly decreased the plasma ET levels ( p < 0.01 ) , significantly changed the plasma ANP and TXB2 levels ( p < 0.05 ) , and significantly increased the plasma 6-keto-PGF1 levels ( p < 0.01 ) in the experimental group compared with those before infusion .